SCTX
Scribe Therapeutics Inc.
16.80$
-2.2%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
Scribe Therapeutics Inc. (SCTX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at -5.3 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 25 | Q2 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|
| -14 | -6.6 | -7.6 | -5.3 | |
| 0.9 | 0.8 | 0.8 | 0.8 | |
| 0.7 | 0.7 | 2.0 | 0.2 | |
| -15 | 1.6 | 1.6 | -1.0 | |
| 0.5 | 0.4 | 0.0 | 0.0 | |
| 0.0 | 0.1 | -0.4 | -1.4 | |
| 7.3 | -3.9 | 7.6 | 15 | |
| -14 | -7.1 | -7.6 | -5.3 |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.